Poor collaboration, lack of information major barriers to implementing family planning methods

NewsGuard 100/100 Score

Ahead of the London Summit on Family Planning on July 11, Gary Darmstadt, head of the Family Health Division of the Bill & Melinda Gates Foundation, examines barriers to contraceptive use in this post in the foundation's "Impatient Optimists" blog. "Poor collaboration in recent years means that donors have not been aligned and, as such, there has been inadequate, inconsistent and unpredictable funding for family planning programs globally," he states, adding, "The other recurring theme of existing barriers is the lack of information at all levels -- global, national, and community level -- about the health benefits of planning and spacing children and the available methods to do that." He concludes, "[U]nderstanding the problem and barriers to planning a family is the first step in establishing an ambitious yet achievable goal and mobilizing the global community behind it" (7/5).   


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New female contraceptive under development: end-user preferences revealed in web-based survey